A Retrospective Study of Metastatic Renal Cell Carcinoma Patients With Brain Metastases

Abstract Metastatic renal cell carcinoma (mRCC) involving the central nervous system is currently an excluded subgroup of patients in the systemic treatment; for this reason, there is no solid data to support the efficacy of therapies in this subgroup. That is why it is important to describe real-li...

Descripción completa

Detalles Bibliográficos
Autores principales: Zapata Laguado, Martin, Paez Quintero, Heliberto, Gomez, Andres, Varela, Rodolfo
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Cureus 2023
Materias:
Oncology
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9939236/
https://www.ncbi.nlm.nih.gov/pubmed/36811042
http://dx.doi.org/10.7759/cureus.34014

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9939236/
https://www.ncbi.nlm.nih.gov/pubmed/36811042
http://dx.doi.org/10.7759/cureus.34014

Ejemplares similares